Latest Earnings Results: Q3 '26
Estimated EPS
-$0.22
Reported EPS
-$0.15
Surprise
+30.96%
Estimated Rev
$588.14M
Reported Rev
$605.1M
Surprise
+2.88%
• Reported GAAP EPS of -$0.15 up 46.43% YoY • Reported revenue of $605.1M down -3.41% YoY • Teladoc Health expects full-year 2026 revenue of $2.4B, adjusted EBITDA of $277M, net loss per share of -$0.95, and free cash flow of $135M.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.12 | -- | -- | N/A |
Q3 '26 | -$0.22 | -$0.15 | 30.96% | BEAT |
Q2 '26 | -$0.25 | -$0.21 | 15.91% | BEAT |
Q1 '26 | -$0.34 | -$0.36 | -5.52% | MISSED |
Q4 '25 | -$0.18 | -$0.14 | 21.92% | BEAT |